Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study
- 14 October 2010
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 30 (1) , 21-27
Abstract
Conclusive data about the prevalence of endothelial dysfunction and atherosclerotic process in ankylosing spondylitis (AS) patients with respect to the general population are lacking. Elevated plasma levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, have been reported in clinical conditions associated with endothelial dysfunction and atherosclerotic disease. We performed a cross-sectional study to evaluate plasma ADMA levels and atherosclerotic disease in AS patients. Seventeen consecutive AS patients free of any cardiovascular disease and 17 healthy controls [strictly matched for sex, age (±5 years) and atherosclerotic risk factors] were recruited. Plasma ADMA levels were assessed by capillary electrophoresis. Common carotid artery intima–media thickness (CCA-IMT), flow-mediated dilatation (FMD) and arterial stiffness (aS) were registered as surrogate markers of atherosclerotic disease. Plasma ADMA levels appeared significantly (p = 0.001) higher in AS patients (0.65 ± 0.10 μmoli/L) than in the control subjects (0.54 ± 0.07 μmoli/L) while no statistically significant differences between AS and controls were demonstrated in CCA-IMT, FMD, and aS. AS patients showed increased plasma ADMA levels with respect to control subjects. On the contrary, we were not able to document a significant difference in atherosclerotic process between patients and controls.Keywords
This publication has 27 references indexed in Scilit:
- Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring CohortStroke, 2009
- Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockadeAnnals of the Rheumatic Diseases, 2009
- Isoform-Specific Regulation by N G , N G -Dimethylarginine Dimethylaminohydrolase of Rat Serum Asymmetric Dimethylarginine and Vascular Endothelium-Derived Relaxing Factor/NOCirculation Research, 2007
- High‐throughput CZE‐UV determination of arginine and dimethylated arginines in human plasmaElectrophoresis, 2007
- Elevated plasma asymmetric dimethyl‐L‐arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritisArthritis & Rheumatism, 2007
- High prevalence of metabolic syndrome in patients with ankylosing spondylitisClinical Rheumatology, 2006
- Impaired endothelial function in patients with ankylosing spondylitisRheumatology, 2005
- Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevanceClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984
- Mortality among Patients with Ankylosing Spondylitis Not Given X-Ray TherapyNew England Journal of Medicine, 1977